AbdulhamidBazarbachiMD

PubMed

• 40 citations
  Comprehensive Review of AL amyloidosis: some practical recommendations.
  Rama Al Hamed, Abdul Hamid Bazarbachi, Ali Bazarbachi, Florent Malard, Jean-Luc Harousseau
  Blood Cancer Journal. 2021-05-18
• 93 citations
  Relapsed refractory multiple myeloma: a comprehensive overview.
  Abdul Hamid Bazarbachi, Rama Al Hamed, Florent Malard, Jean-Luc Harousseau, Mohamad Mohty
  Leukemia. 2019-08-27
• 182 citations
  Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma.
  Mehmet Kemal Samur, Mariateresa Fulciniti, Anil Aktas Samur, Abdul Hamid Bazarbachi, Yu-Tzu Tai
  Nature Communications. 2021-02-08

Journal Articles

• Allogeneic transplant for FLT3-ITD mutated AML: advances and challenges  
  Bazarbachi AH, Al Hamed R, Malard F, Mohty M, Bazarbachi A, Therapeutic Advances in Hematology, 7/2019
• A Phase 2 Study of Hyper-CVAD plus Ofatumumab as Frontline Therapy in CD20+ Acute Lymphoblastic Leukemia (ALL): Updated results  
  Bazarbachi AH, Yilmaz M, Ravandi F, Thomas D, Khouri M, Garcia-Manero G, Garris R, Cortes J, Short N, Sasaki K, Issa G, Koller P, Schroeder H, Kadia T, Verstovsek S, D..., Journal of Clinical Oncology, 5/2018
• How I treat and monitor non-transfusion-dependent thalassaemia  
  Bazarbachi AH, Moukhadder H, Bou Fakhredin R, Roumi J, Chaya B, Taher A, Haematologica, 3/2017
• Immune thrombocytopenia: a comprehensive review from pathophysiology to promising treatment modalities  
  Moukhadder H, Chaya B, Bazarbachi AH, Taher A, Expert Opinion on Orphan Drugs, 10/2016
• Non-Transfusion-Dependent Thalassaemia: A Panoramic Survey from Pathophysiology to Treatment  
  Bazarbachi AH, Chaya B, Moukhadder H, Taher A, EMJ, 7/2016
• Join now to see all

Abstracts/Posters

• Allogeneic stem cell transplantation (allo-SCT) with sequential conditioning in patients with primary refractory or relapsed adult acute lymphoblastic leukemia: a repo...
  Bazarbachi AH, Al Hamed R, Labopin M, Afanasyev B, Hamladji RM, Beelen D, Ganser A, Scheid C, Wu D, Bunjes D, Stepensky P, Tischer J, Kröger N, Peric Z, Giebel S, Nagl..., European Society for Blood and Marrow Transplantation, Frankfurt, DEU, 3/2019
• Azacitidine (AZA) For Prophylaxis or Pre-emptive Therapy for Myeloid Neoplasms After Allogeneic Stem Cell Transplantation
  Marini C, Brissot E, Bazarbachi AH, Dulery R, Sestili S, Battipaglia G, Mediavilla C, Paviglianiti A, Belhocine R, Isnard F, Lapusan S, Adaeva R, Vekhoff A, Ledraa T, ..., European Society for Blood and Marrow Transplantation, Frankfurt, DEU, 3/2019
• A Phase 2 Study of Hyper-CVAD plus Ofatumumab as Frontline Therapy in CD20+ Acute Lymphoblastic Leukemia (ALL): Updated results
  Bazarbachi AH, Yilmaz M, Ravandi F, Thomas D, Khouri M, Garcia-Manero G, Garris R, Cortes J, Short N, Sasaki K, Issa G, Koller P, Schroeder H, Kadia T, Verstovsek S, D..., American Society of Clinical Oncology, Chicago, IL, USA, 6/2018